Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests, Newsroom

A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study.

With New NIH Small Business Innovation Research Award, Temple

PDF) Design and conduct of confirmatory chronic pain clinical trials

Maximizing treatment efficacy through patient stratification in

The assessment of neuropathic pain patients

Dr. Peter Goldstein

iPSCs and DRGs: stepping stones to new pain therapies: Trends in

Therapeutic potential of conopeptides

Potential neuropathic pain treatment shows promise in preclinical

Manipulating nerves to relieve pain without drugs

CBD Oil For Pain: Does It Really Work? – Forbes Health

Dry Eye

Frontiers Preclinical Neuropathic Pain Assessment; the

The Emerging Role of Sigma Receptors in Pain Medicine - Advantx

Akelos